Home
>
National Drug Code (NDC)
>
TRUVADA
TRUVADA - 55154-4425-4 - (emtricitabine and tenofovir disoproxil fumarate)
Drug Information of TRUVADA
| Product NDC: | 55154-4425 |
| Proprietary Name: | TRUVADA |
| Non Proprietary Name: | emtricitabine and tenofovir disoproxil fumarate |
| Active Ingredient(s): | 200; 300 mg/1; mg/1 & nbsp; emtricitabine and tenofovir disoproxil fumarate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of TRUVADA
| Product NDC: | 55154-4425 |
| Labeler Name: | Cardinal Health |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021752 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20040802 |
Package Information of TRUVADA
| Package NDC: | 55154-4425-4 |
| Package Description: | 30 POUCH in 1 CARTON (55154-4425-4) > 1 TABLET, FILM COATED in 1 POUCH (55154-4425-6) |
NDC Information of TRUVADA
| NDC Code | 55154-4425-4 |
| Proprietary Name | TRUVADA |
| Package Description | 30 POUCH in 1 CARTON (55154-4425-4) > 1 TABLET, FILM COATED in 1 POUCH (55154-4425-6) |
| Product NDC | 55154-4425 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | emtricitabine and tenofovir disoproxil fumarate |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20040802 |
| Marketing Category Name | NDA |
| Labeler Name | Cardinal Health |
| Substance Name | EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE |
| Strength Number | 200; 300 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
